# Progress on Omega-3 fatty acids for the comprehensive and targeted treatment of spinal cord injury

**Authors:** Zhongze Yuan, Lusen Shi, Xiao-Na Tao, Xiangchuang Fan, Han Zheng, Yifan Shang, Xiaoqing Zhao, Fan Yang, Hui Lin, Peng Xiao, Bo Chu, Jichuan Qiu, Shaohui Zong, Ning Ran, Xiaohong Kong, Jin-Peng Sun, Hengxing Zhou, Shiqing Feng

PMC · DOI: 10.1038/s41413-025-00461-w · Bone Research · 2026-01-12

## TL;DR

This paper reviews how Omega-3 fatty acids may help treat spinal cord injuries by reducing inflammation and supporting nerve recovery.

## Contribution

The paper highlights new insights into how Omega-3 fatty acids interact with GPR120 to promote spinal cord injury recovery.

## Key findings

- Omega-3 fatty acids show therapeutic potential for spinal cord injury through anti-inflammatory and neurotrophic effects.
- GPR120 activation by Omega-3 fatty acids is key to their beneficial effects in SCI recovery.
- Understanding GPR120 signaling could lead to new drugs for SCI treatment.

## Abstract

Traumatic spinal cord injury (SCI) is a debilitating condition characterized by the impairment of neural circuits, leading to the loss of motor and sensory functions and accompanied by severe complications. Substantial research has reported the therapeutic potential of Omega-3 fatty acids for the central nervous system, particularly after traumatic SCI. Omega-3 fatty acids may contribute to improving SCI recovery through their anti-inflammatory, anti-oxidative, neurotrophic, and membrane integrity-preserving properties. These functions of Omega-3 fatty acids are primarily mediated via the activation of G protein-coupled receptor 120 (GPR120), commonly known as the fish oil-specific receptor. Advancements in understanding of the molecular mechanisms of GPR120’s recognition of Omega-3 fatty acids and its downstream signaling mechanisms has significantly promoted research on the pharmacological potential of Omega-3 fatty acids and the development of highly selective and high-affinity alternatives. This review aims to provide in-depth analysis of the comprehensive therapeutic potential of Omega-3 fatty acids for SCI and its accompanying complications, and the prospects for developing novel drugs based on the recognition of Omega-3 fatty acids by GPR120.

## Linked entities

- **Proteins:** FFAR4 (free fatty acid receptor 4)
- **Chemicals:** Omega-3 fatty acids (PubChem CID 56842239)
- **Diseases:** spinal cord injury (MONDO:0043797)

## Full-text entities

- **Genes:** FFAR4 (free fatty acid receptor 4) [NCBI Gene 338557] {aka BMIQ10, GPR120, GPR129, GT01, O3FAR1, OB10Q}
- **Diseases:** inflammatory (MESH:D007249), Traumatic (MESH:D014947), SCI (MESH:D013119), loss (MESH:D016388)
- **Chemicals:** Omega-3 fatty acids (MESH:D015525)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12791147/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12791147/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12791147/full.md

---
Source: https://tomesphere.com/paper/PMC12791147